Efficacy and Safety of Bevacizumab Biosimilars Compared With Reference Biologics in Advanced Non-small Cell Lung Cancer or Metastatic Colorectal Cancer Patients: A Network Meta-Analysis

Background: Bevacizumab biosimilars are slowly making their way into cancer treatment, but the data on their efficacy and safety in cancer patients are still poor. We systematically summarized the current evidence for the efficacy and safety of bevacizumab biosimilars in patients with advanced non-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xinyi, Zhang, Shengzhao, Xu, Ting, Zhan, Mei, Chen, Chen, Zhang, Chenyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294356/
https://www.ncbi.nlm.nih.gov/pubmed/35865968
http://dx.doi.org/10.3389/fphar.2022.880090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294356/
https://www.ncbi.nlm.nih.gov/pubmed/35865968
http://dx.doi.org/10.3389/fphar.2022.880090

Ejemplares similares